📖

APOC2 Gene

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-apoc2

Related Entities

Metadata

slug	genes-apoc2
entity_type	gene
kg_node_id	APOC2

Linked Artifacts (259)

see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE75%

see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 75%

see_also📖nct0550878975%

see_also📖remternetug-anti-amyloid-alzheimers75%

see_also📖UPenn Observational Research Repository (NCT04715399)75%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer70%

mentions🧪APOE Isoform Conversion Therapy70%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones70%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction70%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy70%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy70%

mentions🧪Competitive APOE4 Domain Stabilization Peptides70%

mentions🧪APOE Isoform Expression Across Glial Subtypes70%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and70%

see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739270%

see_also📖APOE2 (Apolipoprotein E2)70%

see_also📖APOE3 (Apolipoprotein E3)70%

see_also📖APOE4 (Apolipoprotein E4)70%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer63%

related🧪APOE Isoform Conversion Therapy63%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones63%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction63%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy63%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides63%

related🧪APOE4-Selective Lipid Nanoemulsion Therapy63%

related🧪Competitive APOE4 Domain Stabilization Peptides63%

related🧪APOE Isoform Expression Across Glial Subtypes63%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration60%

see_also📖Exosomal Biomarkers in Neurodegeneration60%

see_also📖Exosomal miR-155 in Neurodegeneration60%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration60%

see_also📖Liquid Biopsy in Neurodegeneration60%

see_also📖Metabolomic Biomarkers in Neurodegeneration60%

see_also📖Neuroimaging Biomarkers for Neurodegeneration60%

see_also📖Synaptic Biomarkers in Neurodegeneration60%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl60%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 60%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)60%

see_also📖China Neurodegeneration Epidemiology60%

see_also📖DALY Methodology — Neurodegeneration60%

see_also📖Disease Progression & Staging in Neurodegeneration60%

see_also📖Economic Burden — Neurodegeneration60%

see_also📖European Neurodegeneration Epidemiology60%

see_also📖Familial vs Sporadic Neurodegeneration Comparison60%

see_also📖Global Neurodegeneration Epidemiology60%

see_also📖India Neurodegeneration Epidemiology60%

see_also📖Japan Neurodegeneration Epidemiology60%

see_also📖Manganese-Related Neurodegeneration (Manganism)60%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison60%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr60%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 60%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)60%

see_also📖Potential Impact Measures — Neurodegeneration60%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)60%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)60%

see_also📖Sleep Disorders in Neurodegeneration60%

see_also📖US Neurodegeneration Epidemiology60%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread60%

see_also📖acetylcholine-signaling-neurodegeneration60%

see_also📖Advanced Glycation End Products in Neurodegeneration60%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 60%

see_also📖Amylin Signaling in Neurodegeneration60%

see_also📖Antibody Therapy in Neurodegeneration60%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration60%

see_also📖Autosis Pathway in Neurodegeneration60%

see_also📖Axon Guidance Pathways in Neurodegeneration60%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration60%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain60%

see_also📖CaMKII Signaling Pathway in Neurodegeneration60%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration60%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration60%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration60%

see_also📖Cholinergic System Dysfunction in Neurodegeneration60%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat60%

see_also📖Neural Circuits in Neurodegeneration60%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration60%

see_also📖Computational Disease Models for Neurodegeneration60%

see_also📖Convergent Pathways in Neurodegeneration60%

see_also📖Copper Homeostasis in Neurodegeneration60%

see_also📖COVID-19 Neurodegeneration Mechanism60%

see_also📖Diffusion MRI (DTI) in Neurodegeneration60%

see_also📖Digital Phenotyping in Neurodegeneration60%

see_also📖Down Syndrome Neurodegeneration Pathway60%

see_also📖Dystrophic Neurites in Neurodegeneration60%

see_also📖Endocannabinoid System in Neurodegeneration60%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration60%

see_also📖Endosomal Sorting Defects in Neurodegeneration60%

see_also📖Endothelin Signaling Pathway in Neurodegeneration60%

see_also📖epigenetics-neurodegeneration60%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration60%

see_also📖FA2H-Associated Neurodegeneration Pathway60%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration60%

see_also📖Galectin-3 Mechanism in Neurodegeneration60%

see_also📖Gangliosides in Neurodegeneration60%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration60%

see_also📖GDNF Signaling Pathway in Neurodegeneration60%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration60%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration60%

see_also📖Glycosylation in Neurodegeneration60%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration60%

see_also📖Hippocampal Neurogenesis in Neurodegeneration60%

see_also📖Histone Modification Pathways in Neurodegeneration60%

see_also📖HMGB1 Signaling in Neurodegeneration60%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration60%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration60%

see_also📖IL-1 Signaling Pathway in Neurodegeneration60%

see_also📖Integrated Stress Response in Neurodegeneration60%

see_also📖interleukin-6-signaling-neurodegeneration60%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration60%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 60%

see_also📖Kidney-Brain Neurodegeneration Axis60%

see_also📖Lipid Dysregulation in Neurodegeneration60%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration60%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration60%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration60%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration60%

see_also📖Metal Homeostasis in Neurodegeneration60%

see_also📖Microglial Priming Pathway in Neurodegeneration60%

see_also📖MicroRNA Dysfunction in Neurodegeneration60%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration60%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration60%

see_also📖Mitochondrial Fusion in Neurodegeneration60%

see_also📖Molecular Chaperones in Neurodegeneration60%

see_also📖mTOR Signaling in Neurodegeneration60%

see_also📖mTOR Signaling Pathway in Neurodegeneration60%

see_also📖Neural Circuit Disruption in Neurodegeneration60%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N60%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati60%

see_also📖Neuronal Hyperexcitability in Neurodegeneration60%

see_also📖Neuropil Threads in Neurodegeneration60%

see_also📖Neurotensin Signaling in Neurodegeneration60%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration60%

see_also📖NF-kB Signaling Pathway in Neurodegeneration60%

see_also📖Nitric Oxide Signaling in Neurodegeneration60%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration60%

see_also📖Neuropeptide Y Signaling in Neurodegeneration60%

see_also📖NRF2 Signaling Pathway in Neurodegeneration60%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration60%

see_also📖Orexin Signaling in Neurodegeneration60%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration60%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration60%

see_also📖Paranodal Dysfunction in Neurodegeneration60%

see_also📖Paraptosis in Neurodegeneration60%

see_also📖Parthanatos in Neurodegeneration60%

see_also📖Pericyte Loss in Neurodegeneration60%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration60%

see_also📖PKR Pathway in Neurodegeneration60%

see_also📖PPAR Signaling Pathway in Neurodegeneration60%

see_also📖Prion Diseases in Neurodegeneration60%

see_also📖Prion-Like Spread in Neurodegeneration60%

see_also📖Prion Protein Metabolism in Neurodegeneration60%

see_also📖Progesterone Signaling Pathway in Neurodegeneration60%

see_also📖Prognostic Biomarkers in Neurodegeneration60%

see_also📖Protein Aggregation Comparison in Neurodegeneration60%

see_also📖Protein Aggregation Seeds in Neurodegeneration60%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration60%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su60%

see_also📖Purinergic Signaling in Neurodegeneration60%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener60%

see_also📖R-Loop Stress in Neurodegeneration60%

see_also📖RAN Translation in Neurodegeneration60%

see_also📖Retinal Degeneration Pathway in Neurodegeneration60%

see_also📖Ribosome Dysfunction in Neurodegeneration60%

see_also📖RNA Splicing in Neurodegeneration60%

see_also📖RNA-Targeted Therapies in Neurodegeneration60%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a60%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration60%

see_also📖Senescent Cell Clearance in Neurodegeneration60%

see_also📖Serotonergic Dysfunction in Neurodegeneration60%

see_also📖Sex Differences in Neurodegeneration60%

see_also📖Short Chain Fatty Acids in Neurodegeneration60%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration60%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration60%

see_also📖Sleep Dysfunction in Neurodegeneration60%

see_also📖SUMOylation in Neurodegeneration60%

see_also📖synaptic-vesicle-cycling-neurodegeneration60%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration60%

see_also📖T-Cell Dysfunction in Neurodegeneration60%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration60%

see_also📖Therapeutic Targets in Neurodegeneration60%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration60%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration60%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration60%

see_also📖Vagus Nerve Pathway in Neurodegeneration60%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio60%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio60%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen60%

see_also📖WNK1 Kinase in Neurodegeneration60%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration60%

see_also📖ABCA1 - ATP-Binding Cassette Transporter A160%

see_also📖ABCA2 Gene - ATP Binding Cassette Subfamily A Member 260%

see_also📖APOC1 Gene — Apolipoprotein C-I60%

see_also📖APOC3 Gene60%

see_also📖LRP8 Gene60%

see_also📖APOA1 Gene60%

see_also📖APOA2 Gene60%

see_also📖COL4A1 Gene60%

see_also📖LZTS1 — Leucine Zipper Tumor Suppressor 160%

see_also📖mcc60%

see_also📖Alzheimer Indonesia60%

see_also📖Packard Center for ALS Research60%

see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%

see_also📖HNF4A - Hepatocyte Nuclear Factor 4 Alpha60%

see_also📖LIPA Gene60%

see_also📖ppara60%

see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh55%

see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime55%

see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di55%

mentions🧪Complement C1q Mimetic Decoy Therapy50%

mentions🧪CYP46A1 Overexpression Gene Therapy50%

mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

related🔬What are the mechanisms underlying synaptic pruning by micro50%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

related🧪APOE Isoform Conversion Therapy50%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

related🧪APOE4-Selective Lipid Nanoemulsion Therapy50%

related🧪Competitive APOE4 Domain Stabilization Peptides50%

related🧪APOE Isoform Expression Across Glial Subtypes50%

related🧪LRP1-Dependent Tau Uptake Disruption50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

related🔬What are the mechanisms underlying synaptic pruning by micro50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🧪Ganglioside Rebalancing Therapy50%

related🧪Sphingomyelin Synthase Activators for Raft Remodeling50%

related🧪Membrane Cholesterol Gradient Modulators50%

see_also📖al002-trem2-agonist-alzheimers50%

see_also📖CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD50%

see_also📖DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulat50%

see_also📖Donanemab TRAILBLAZER-ALZ 2 Trial50%

see_also📖MK-1167 Phase 2 AD Trial (MK-1167-008)50%

see_also📖A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month50%

see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M50%

see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial50%

see_also📖Trontinemab (RO7126209) Phase 3 Trial — TRONTIER 2 (NCT0717050%

see_also📖UB-311 Alzheimer's Vaccination Trial50%

see_also🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

see_also🧪APOE Isoform Conversion Therapy50%

see_also🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

see_also🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

see_also🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

see_also🧪APOE4-Selective Lipid Nanoemulsion Therapy50%

see_also🧪Competitive APOE4 Domain Stabilization Peptides50%

see_also🧪APOE Isoform Expression Across Glial Subtypes50%

see_also🧪LRP1-Dependent Tau Uptake Disruption50%

see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058245%

see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06745%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

related🧪Complement C1q Mimetic Decoy Therapy40%

related🧪CYP46A1 Overexpression Gene Therapy40%

related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%

mentions🔬What are the mechanisms underlying synaptic pruning by micro35%